4//SEC Filing
EASTLAND JULIA MARIE 4
Accession 0001725160-25-000036
CIK 0001725160other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 6:29 PM ET
Size
7.4 KB
Accession
0001725160-25-000036
Insider Transaction Report
Form 4
EASTLAND JULIA MARIE
DirectorCEO & President
Transactions
- Award
Stock Option (Right to Buy)
2025-02-03+59,388→ 59,388 totalExercise: $1.68Exp: 2035-02-02→ Common Stock (59,388 underlying) - Award
Common Stock
2025-02-03+59,388→ 87,888 total
Footnotes (2)
- [F1]Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a two year period following the grant date, subject to the Reporting Person's continued service with the Issuer.
- [F2]The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.
Documents
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
Related Parties
1- filerCIK 0001500189
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 6:29 PM ET
- Size
- 7.4 KB